ChatGPT

Artificial Intelligence

AI-Powered Partnership Promises Leap in Cancer Therapy with $8 Million Deal

AI-Powered Partnership Promises Leap in Cancer Therapy with $8 Million Deal

March 13, 2025
ImmunoPrecise Antibodies collaborates with a biotech company to revolutionize cancer treatment through Antibody-Drug Conjugates (ADCs) and bispecific antibodies. The partnership, valued between $8-10 million, lasts 18-24 months and utilizes IPA’s B-cell Select™ platform and AI-driven discovery capabilities. IPA’s LENSai™ technology enhances therapeutic development by using AI to model and analyze multi-omic data, streamlining antibody optimization and production. The collaboration aims

Data Privacy

AI Ethics

The AI Revolution’s Next Frontier: Are Marketers Prepared for a Non-Human Audience?

The AI Revolution’s Next Frontier: Are Marketers Prepared for a Non-Human Audience?

March 5, 2025
Artificial intelligence is evolving into “agentic AI,” acting autonomously in digital environments and reshaping business communications. Agentic AI can perform complex tasks without human intervention, such as booking travel arrangements, impacting how marketers engage with audiences. The traditional emotional core of marketing may be threatened, as focus shifts from appealing directly to consumers to influencing AI-driven decision-making processes. Marketing strategies

Latest

AI-Powered Partnership Promises Leap in Cancer Therapy with $8 Million Deal

AI-Powered Partnership Promises Leap in Cancer Therapy with $8 Million Deal

March 13, 2025
ImmunoPrecise Antibodies collaborates with a biotech company to revolutionize cancer treatment through Antibody-Drug Conjugates (ADCs) and bispecific antibodies. The partnership, valued between $8-10 million, lasts 18-24 months and utilizes IPA’s B-cell Select™ platform and AI-driven discovery capabilities. IPA’s LENSai™ technology enhances therapeutic
1 2 3 904
Privacy policy
Contact